Jaythari Tablet
Product Images NDC 70710-1749
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Jaythari (NDC 70710-1749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
6 mg Label (069aa814 389f 4346 934c 5dc8469aef98 02)
18 mg Label (069aa814 389f 4346 934c 5dc8469aef98 03)
This is a description for "Jaythari" tablets containing deflazacort for oral use. The dosage and administration details are provided in the package insert. The tablets should be dispensed in a light-resistant container and stored at 20°C to 25°C (66°F to 77°F) with excursions permitted up to 15°C to 30°C (59°F to 86°F). The package is child-resistant, and it is advised to keep all drugs out of children's reach. The tablets are distributed by Doppel Farmaceutici in Piacenza, Italy, and in the USA by Zydas Pharmaceuticals Inc. in Pennington, NJ.*
30 mg Label (069aa814 389f 4346 934c 5dc8469aef98 04)
36 mg Label (069aa814 389f 4346 934c 5dc8469aef98 05)
6 mg Carton (069aa814 389f 4346 934c 5dc8469aef98 06)
18 mg Carton (069aa814 389f 4346 934c 5dc8469aef98 07)
30 mg Carton (069aa814 389f 4346 934c 5dc8469aef98 08)
36 mg Carton (069aa814 389f 4346 934c 5dc8469aef98 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.